Sukumaran Geethi Krishna, Sunanda Asha Chellappan, George Shajul
Department of ENT, Government Medical College, Kottayam, Kerala, India.
Int Arch Otorhinolaryngol. 2024 Oct 25;28(4):e603-e607. doi: 10.1055/s-0044-1786832. eCollection 2024 Oct.
In children, obstructive sleep apnea (OSA) is a sleep-related breathing disorder that is caused by adenotonsillar hypertrophy and is characterized by upper airway obstruction disturbing sleep. We conducted this study to evaluate health-related quality of life (QoL) in children with OSA before and after adenotonsillectomy. A descriptive, observational study was conducted among 43 children in the 4-to-12 years old age group who had symptoms of OSA due to adenotonsillar hypertrophy and who underwent adenotonsillectomy at a tertiary care center during the period from February 2020 to February 2021. The QoL was assessed using the OSA-18 questionnaire preoperatively and at 2 and 6 months postoperatively. Among the study population, males (72)%) were more affected with OSA, with a male-to-female ratio of 2.6:1. Based on the OSA-18 questionnaire assessment, the most severe and frequently observed symptoms were in the domains of sleep disturbance and physical symptoms, in which the mean score was 77 preoperatively. After adenotonsillectomy, the mean OSA-18 score decreased to 28.605 and 22.465 at 2 and 6 months, respectively. At 2 months postsurgery, more significant improvement was noticed in sleep disturbances, physical symptoms, and parent's concern while at 6 months postsurgery, all domains showed equal improvement. Therefore, following adenotonsillectomy, the QoL improved significantly. Obstructive sleep apnea can adversely affect sleep quality as well as neurocognitive and cardiovascular functions. Adenotonsillectomy resulted in significant improvement in the QoL.
在儿童中，阻塞性睡眠呼吸暂停（OSA）是一种与睡眠相关的呼吸障碍，由腺样体扁桃体肥大引起，其特征是上呼吸道阻塞干扰睡眠。我们进行这项研究以评估腺样体扁桃体切除术前和术后儿童阻塞性睡眠呼吸暂停患者的健康相关生活质量（QoL）。在2020年2月至2021年2月期间，对一家三级医疗中心43名4至12岁因腺样体扁桃体肥大出现阻塞性睡眠呼吸暂停症状并接受腺样体扁桃体切除术的儿童进行了一项描述性观察研究。使用OSA - 18问卷在术前、术后2个月和6个月评估生活质量。在研究人群中，男性（72%）受阻塞性睡眠呼吸暂停影响更大，男女比例为2.6:1。根据OSA - 18问卷评估，最严重且最常观察到的症状出现在睡眠障碍和身体症状领域，术前平均得分为77分。腺样体扁桃体切除术后，OSA - 18平均得分在术后2个月和6个月分别降至28.605和22.465。术后2个月，睡眠障碍、身体症状和家长关注方面有更显著改善，而术后6个月，所有领域均有同等程度改善。因此，腺样体扁桃体切除术后，生活质量有显著改善。阻塞性睡眠呼吸暂停会对睡眠质量以及神经认知和心血管功能产生不利影响。腺样体扁桃体切除术使生活质量有显著改善。
